COVID-19 Severity of Illness Categories

Accurate classification of COVID-19 severity is essential for determining the appropriate level of care, guiding treatment decisions, predicting prognosis, and identifying patients who require hospitalization, intensive monitoring, or critical care. Disease severity should be assessed using a combination of clinical symptoms, physical examination, oxygenation status, laboratory findings, and imaging studies, and patients should be reassessed regularly as their condition may deteriorate rapidly.

1. Asymptomatic or Pre-symptomatic Infection

Patients with asymptomatic or pre-symptomatic infection have laboratory-confirmed SARS-CoV-2 infection, detected by a nucleic acid amplification test (NAAT), such as real-time reverse transcription polymerase chain reaction (rRT-PCR), or a validated antigen test, but have no symptoms or signs consistent with COVID-19 at the time of diagnosis.

Pre-symptomatic individuals may subsequently develop symptoms during the incubation period, whereas asymptomatic individuals remain symptom-free throughout the course of infection. Despite the absence of symptoms, both groups can transmit the virus and therefore require appropriate isolation and public health measures.

Clinical Features

• Positive SARS-CoV-2 laboratory test

• No fever or respiratory symptoms

• Normal oxygen saturation

• Normal physical examination

• May have normal chest imaging if performed

2. Mild Illness

Patients with mild COVID-19 have symptoms suggestive of acute viral infection but no evidence of lower respiratory tract involvement, hypoxemia, or abnormal chest imaging.

Common symptoms include:

• Fever

• Dry cough

• Sore throat

• Fatigue or malaise

• Headache

• Myalgia

• Chills

• Nasal congestion or runny nose

• Loss of smell (anosmia)

• Loss of taste (ageusia)

• Nausea

• Vomiting

• Diarrhea

Patients do not have:

• Shortness of breath

• Dyspnea

• Hypoxia

• Clinical evidence of pneumonia

• Abnormal chest imaging attributable to COVID-19

Most patients recover with supportive care and close outpatient monitoring, although individuals at high risk for severe disease may require early antiviral therapy where indicated.

3. Moderate Illness

Moderate COVID-19 is characterized by evidence of lower respiratory tract disease identified through clinical assessment or imaging while maintaining adequate oxygenation.

Clinical findings may include:

• Clinical signs of pneumonia

• Persistent cough

• Mild dyspnea

• Crackles on chest auscultation

• Radiographic evidence of pulmonary infiltrates or ground-glass opacities

Patients maintain:

• Oxygen saturation (SpO₂) ≥94% on room air at sea level

These patients generally require hospital assessment, close observation, and supportive treatment because clinical deterioration may occur rapidly during this stage.

4. Severe Illness

Severe COVID-19 is defined by significant respiratory compromise or extensive pulmonary involvement. Patients meet one or more of the following criteria:

• Oxygen saturation (SpO₂) <94% on room air at sea level

• PaO₂/FiO₂ ratio <300 mmHg

• Respiratory rate >30 breaths per minute

• Lung infiltrates involving more than 50% of the lung fields on chest imaging within 24–48 hours

Clinical manifestations often include:

• Severe shortness of breath

• Marked tachypnea

• Increased work of breathing

• Persistent hypoxemia

• Cyanosis

• Difficulty speaking in full sentences

• Signs of impending respiratory failure

Patients with severe disease require hospitalization, supplemental oxygen therapy, close physiological monitoring, and timely escalation of treatment to prevent progression to critical illness.

5. Critical Illness

Critical COVID-19 represents the most severe stage of disease and is characterized by life-threatening organ dysfunction requiring intensive care.

Patients may present with one or more of the following:

• Acute respiratory failure requiring high-flow oxygen, non-invasive ventilation, or invasive mechanical ventilation

• Acute Respiratory Distress Syndrome (ARDS)

• Septic shock

• Multiple organ dysfunction syndrome (MODS)

• Acute kidney injury requiring renal replacement therapy

• Acute cardiac injury or myocarditis

• Severe thromboembolic complications

• Altered mental status due to critical illness

These patients require comprehensive multidisciplinary management in a high-dependency unit or intensive care unit (ICU), including advanced respiratory support, hemodynamic stabilization, organ support, prevention of complications, and continuous monitoring.

Summary of COVID-19 Severity Categories

Clinical Note

COVID-19 severity is dynamic rather than static. Patients with initially mild or moderate disease may deteriorate rapidly, particularly between the second and third week of illness. Regular reassessment of symptoms, respiratory status, oxygen saturation, laboratory markers, and imaging findings is therefore essential to ensure timely recognition of disease progression and appropriate escalation of care.